Common Names
Geographic Range: Indian subcontinent, North Africa, Middle East; cultivated worldwide in dry subtropical regions
Known Contraindications
1
Compounds
3
Traditions
3
Treatments
3
Conditions
CC(C1CC[C@@]2([C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C)C(=O)O[C@@H]1OC2(CO2)C1OCYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | no significant interaction |
| CYP2C9 | weak inhibitor |
| CYP2D6 | weak substrate |
| CYP3A4 | moderate inhibitor |
| CYP2C19 | no significant interaction |
| clinical_note | Moderate CYP3A4 inhibition; may increase levels of CYP3A4 substrates (e.g. cyclosporine, statins) |